GRN | SLV | GRN / SLV | |
Gain YTD | 1.657 | 12.381 | 13% |
Net Assets | 25M | 14.3B | 0% |
Total Expense Ratio | N/A | N/A | - |
Turnover | N/A | N/A | - |
Yield | 0.00 | 0.00 | - |
Fund Existence | 5 years | 19 years | - |
SLV | |
---|---|
RSI ODDS (%) | 3 days ago89% |
Stochastic ODDS (%) | 3 days ago90% |
Momentum ODDS (%) | 3 days ago90% |
MACD ODDS (%) | N/A |
TrendWeek ODDS (%) | 3 days ago90% |
TrendMonth ODDS (%) | 3 days ago89% |
Advances ODDS (%) | 11 days ago88% |
Declines ODDS (%) | N/A |
BollingerBands ODDS (%) | 3 days ago86% |
Aroon ODDS (%) | 3 days ago90% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
FPHAX | 27.37 | 0.29 | +1.07% |
Fidelity Select Pharmaceuticals Port | |||
QBDSX | 8.03 | 0.01 | +0.12% |
Quantified Managed Income Investor | |||
JMNCX | 12.68 | -0.10 | -0.78% |
JPMorgan Research Market Neutral C | |||
SUWIX | 34.91 | -0.68 | -1.91% |
DWS Core Equity Inst | |||
PSMPX | 5.47 | -2.66 | -32.69% |
Penn Capital Mid Cap Core Inst |